Beneficial Effects of Nebivolol in Comparison with Atenolol on Safety and Tolerability in Essential Hypertension
Published: June 1, 2014 | DOI: https://doi.org/10.7860/JCDR/2014/.4419
Vivek V. Bhosale, S.C. Inamdar, Karande V.B., Burute S.R., Murthy M.B., Ghatak A.
1. Scientist, Clinical and Experimental Medicine, CSIR-Central Drug Research Institute, Lucknow, India.
2. Associate Professor, Department of Pharmacology, Government Medical College, Miraj, Maharashtra, India.
3. Lecturer, Department of Pharmacology, Government Medical College, Miraj, Maharashtra, India.
4. Lecturer, Department of Pharmacology, Government Medical College, Miraj, Maharashtra, India.
5. Lecturer, Department of Pharmacology, Government Medical College, Miraj, Maharashtra, India.
6. Chief Scientist, Clinical and Experimental Meidcine, CSIR-Central Drug Research Institute, Lucknow, India.
Correspondence Address :
Dr. Vivek V. Bhosale, Scientist, Clinical and Experimental Medicine, CSIR-Central Drug Research Institute
Communication Number-8682, BS10/1 Sector-10 Jankipuram Extension, Sitapur Road, Lucknow-226031, Uttar Pradesh, India.
Phone: +919450902041, E-mail: Vivek_bhosale@yahoo.com
Keywords
Hypertension, Nebivolol, Atenolol